Related Experiment Video
Updated: Oct 13, 2026
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Anti-Inflammatory Effect of Ginsenoside Rg1 on LPS-Induced Septic Encephalopathy and Associated Mechanism
Yuan Chen1, Miaomiao Chi1, Xinyu Qiao1
1Department of Neurosurgery, Municipal Hospital Affiliated to Taizhou University, Taizhou 318000, China.
Insights
Ginsenoside Rg1 demonstrates neuroprotective effects against septic encephalopathy by reducing inflammation and cell damage. This study suggests Rg1 as a potential therapeutic agent for this severe condition.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Sepsis, a systemic inflammatory response post-infection, is a leading cause of mortality.
- Septic encephalopathy, a severe central nervous system dysfunction, particularly affects children, leading to high morbidity and mortality.
Purpose of the Study:
- To investigate the neuroprotective mechanisms of ginsenoside Rg1 in the context of septic encephalopathy.
- To evaluate the efficacy of ginsenoside Rg1 in mitigating the cellular and molecular damage associated with septic encephalopathy.
Main Methods:
- Assessed the impact of ginsenoside Rg1 on cell viability, cytotoxicity, reactive oxygen species (ROS) production, and apoptosis in an in vitro model.
- Utilized qPCR and ELISA to measure inflammatory markers (IL-1β, IL-6, TNF-α, etc.) and western blot to analyze signaling pathway activation (NF-κB, MAPK).
- Conducted histological examination of brain tissue in an in vivo rat model of septic encephalopathy.
Main Results:
- Lipopolysaccharide (LPS) induction significantly increased cytotoxicity, ROS, apoptosis, and inflammatory cytokine production, while decreasing cell viability and causing brain damage.
- Ginsenoside Rg1 treatment significantly ameliorated LPS-induced damage, reduced inflammatory responses, and decreased the activation of NF-κB and MAPK signaling pathways.
- Rg1 treatment notably reduced the expression of key inflammatory mediators including IL-1β, IL-6, IL-10, TNF-α, and MCP-1.
Conclusions:
- Ginsenoside Rg1 effectively inhibits the activation of NF-κB and MAPK signaling pathways, thereby suppressing the production of pro-inflammatory cytokines and chemokines.
- These findings highlight ginsenoside Rg1 as a promising therapeutic candidate for treating septic encephalopathy.
Background:
Sepsis frequently occurs in patients after infection and is highly associated with death. Septic encephalopathy is characterized by dysfunction of the central nervous system, of which the root cause is a systemic inflammatory response. Sepsis-associated encephalopathy is a severe disease that frequently occurs in children, resulting in high morbidity and mortality.
Objectives:
In the present study, we aimed to investigate the neuroprotective mechanism of ginsenoside Rg1 in response to septic encephalopathy.
Methods:
Effects of ginsenoside Rg1 on septic encephalopathy were determined by cell viability, cytotoxicity, ROS responses, apoptosis assays, and histological examination of the brain. Inflammatory activities were evaluated by expression levels of IL-1β, IL-6, IL-10, TNF-α, and MCP-1 using qPCR and ELISA. Activities of signaling pathways in inflammation were estimated by the production of p-Erk1/2/Erk1/2, p-JNK/JNK, p-p38/p38, p-p65/p65, and p-IkBα/IkBα using western blot.
Results:
LPS simulation resulted in a significant increase in cytotoxicity, ROS responses, and apoptosis and a significant decrease in cell viability in CTX TNA2 cells, as well as brain damage in rats. Moreover, the production of IL-1β, IL-6, IL-10, TNF-α, and MCP-1 was reported to be significantly stimulated in CTX TNA2 cells and the brain, confirming the establishment of in vitro and in vivo models of septic encephalopathy. The damage and inflammatory responses induced by LPS were significantly decreased by treatment with Rg1. Western blot analyses indicated that Rg1 significantly decreased the production of p-Erk1/2/Erk1/2, p-JNK/JNK, p-p38/p38, p-p65/p65, and p- IkBα/IkBα in LPS-induced CTX TNA2 cells and brain.
Conclusion:
These findings suggested that Rg1 inhibited the activation of NF-κB and MAPK signaling pathways, which activate the production of proinflammatory cytokines and chemokines. The findings of this study suggested that ginsenoside Rg1 is a candidate treatment for septic encephalopathy.
